Nationwide Fund Advisors’s Viridian Therapeutics VRDN Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-469	Closed	-$64K	–	2047
2017 Q3	$64K	Buy	469 +35	+8%	+$4.78K	﹤0.01%	3012
2017 Q2	$84K	Buy	+434	New	+$84K	﹤0.01%	2965